J Donocik

858 total citations · 1 hit paper
10 papers, 534 citations indexed

About

J Donocik is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Molecular Biology. According to data from OpenAlex, J Donocik has authored 10 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 3 papers in Biological Psychiatry and 2 papers in Molecular Biology. Recurrent topics in J Donocik's work include Schizophrenia research and treatment (4 papers), Tryptophan and brain disorders (3 papers) and Functional Brain Connectivity Studies (2 papers). J Donocik is often cited by papers focused on Schizophrenia research and treatment (4 papers), Tryptophan and brain disorders (3 papers) and Functional Brain Connectivity Studies (2 papers). J Donocik collaborates with scholars based in United Kingdom, Italy and United States. J Donocik's co-authors include Sameer Jauhar, Oliver Howes, Katherine Beck, Toby Pillinger, Anthony J. Cleare, Abebaw Fekadu, Charles A. Mein, Rosamond Nuamah, Nicholas J. Bray and Ricardo Sáinz‐Fuertes and has published in prestigious journals such as Molecular Psychiatry, Journal of Affective Disorders and Schizophrenia Bulletin.

In The Last Decade

J Donocik

10 papers receiving 531 citations

Hit Papers

Impaired Glucose Homeostasis in First-Episode Schizophrenia 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Donocik United Kingdom 6 281 115 115 93 84 10 534
Alma Mihaljević Peleš Croatia 15 222 0.8× 153 1.3× 57 0.5× 69 0.7× 43 0.5× 26 575
Po Wu Gean Taiwan 10 210 0.7× 137 1.2× 46 0.4× 93 1.0× 59 0.7× 11 528
Odette Peerbooms Netherlands 8 186 0.7× 68 0.6× 137 1.2× 206 2.2× 50 0.6× 9 633
Neda Sharifi Iran 6 241 0.9× 175 1.5× 138 1.2× 61 0.7× 156 1.9× 14 541
Luke Vano United Kingdom 5 545 1.9× 122 1.1× 178 1.5× 109 1.2× 129 1.5× 10 823
Andrew Miranda Canada 8 256 0.9× 118 1.0× 91 0.8× 44 0.5× 97 1.2× 10 516
Kenya A. Costa-Dookhan Canada 9 193 0.7× 60 0.5× 101 0.9× 71 0.8× 75 0.9× 14 373
Javier Vázquez-Bourgón Spain 16 464 1.7× 111 1.0× 88 0.8× 80 0.9× 108 1.3× 77 793
Chathurie Suraweera Sri Lanka 9 308 1.1× 53 0.5× 147 1.3× 82 0.9× 116 1.4× 26 581
Nabilah I. Chowdhury Canada 15 286 1.0× 61 0.5× 142 1.2× 180 1.9× 146 1.7× 21 685

Countries citing papers authored by J Donocik

Since Specialization
Citations

This map shows the geographic impact of J Donocik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Donocik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Donocik more than expected).

Fields of papers citing papers by J Donocik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Donocik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Donocik. The network helps show where J Donocik may publish in the future.

Co-authorship network of co-authors of J Donocik

This figure shows the co-authorship network connecting the top 25 collaborators of J Donocik. A scholar is included among the top collaborators of J Donocik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Donocik. J Donocik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schubert, Julia, Mariasavina Severino, James Davies, et al.. (2025). GABAA receptor availability in clinical high-risk and first-episode psychosis: a [11C]Ro15-4513 positron emission tomography study. Molecular Psychiatry. 31(2). 987–996. 1 indexed citations
2.
Jauhar, Sameer, Ilaria Bonoldi, Gonzalo Salazar de Pablo, et al.. (2021). Early intervention in psychosis during the COVID-19 pandemic: Maudsley recommendations. European Neuropsychopharmacology. 47. 130–135. 7 indexed citations
3.
Millgate, Edward, Eugenia Kravariti, Alice Egerton, et al.. (2021). Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study. BMJ Open. 11(11). e054160–e054160. 2 indexed citations
4.
Fekadu, Abebaw, J Donocik, & Anthony J. Cleare. (2018). Standardisation framework for the Maudsley staging method for treatment resistance in depression. BMC Psychiatry. 18(1). 100–100. 57 indexed citations
5.
McCutcheon, Robert A., Katherine Beck, Enrico D’Ambrosio, et al.. (2017). Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia. Acta Psychiatrica Scandinavica. 137(1). 39–46. 64 indexed citations
6.
Pillinger, Toby, et al.. (2017). Impaired Glucose Homeostasis in First-Episode Schizophrenia. JAMA Psychiatry. 74(3). 261–261. 327 indexed citations breakdown →
7.
Rogdaki, Maria, Maria Gudbrandsen, Eileen Daly, et al.. (2017). 142. State or Trait? Investigation of Dopamine Function in Individuals With 22q11 Deletion. Schizophrenia Bulletin. 43(suppl_1). S75–S75. 1 indexed citations
8.
Hill, Matthew, J Donocik, Rosamond Nuamah, et al.. (2014). Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells. Schizophrenia Research. 153(1-3). 225–230. 52 indexed citations
9.
Wooderson, Sarah C., Mário F. Juruena, Abebaw Fekadu, et al.. (2010). Prospective evaluation of specialist inpatient treatment for refractory affective disorders. Journal of Affective Disorders. 131(1-3). 92–103. 21 indexed citations
10.
Donocik, J, et al.. (1999). [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].. PubMed. 56(10). 664–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026